Dr. Ibrahim H. Abou Daya, MD

Dr. Abou Daya practices at MyMichigan Medical Center Midland in Midland, Michigan, part of MyMichigan Health.

Dr. Abou Daya's NPI, 1790950715, was assigned on April 30, 2008. Dr. Abou Daya holds Indiana license 01081381A.

Dr. Abou Daya's primary practice is MyMichigan Medical Center Midland, at 4000 Wellness Drive, Midland, MI 48670 in Midland County. The practice phone is (989) 839-3000.

Dr. Abou Daya's primary practice is MyMichigan Medical Center Midland in Midland, Michigan, part of MyMichigan Health. Dr. Abou Daya is also affiliated with Parkview Regional Medical Center. The medical group on file is MyMichigan Medical Center Midland. Dmand AI also links Dr. Abou Daya to 6 more hospitals, 6 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abou Daya practices, 10 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Abou Daya's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Abou Daya's licenses on file in 3 states: Indiana, Michigan and Wisconsin.

CMS data shows 562 Medicare services from Dr. Abou Daya across 7 procedure codes in 2024, for 290 Medicare patients. Medicare paid $45,356 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 290 Medicare patients who saw Dr. Abou Daya in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abou Daya's median patient age at 73, with 49% women.

In 2024, Dr. Abou Daya wrote 205 Medicare Part D claims for 46 patients. 41% of them were for generic drugs. CMS names the drug for 113 of them, across 5 drugs with 11 or more claims each, at $46,373 in total drug cost. In 2020, CMS named 267 claims across 12 drugs.

Dr. Abou Daya accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abou Daya as offering telehealth.

CMS Open Payments shows 45 general payments to Dr. Abou Daya from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Sunovion Pharmaceuticals Inc. paid the most, $194.